ATI RN
ATI RN Pharmacology 2019 II Questions
Extract:
Question 1 of 5
A nurse is providing teaching to a client who has a new prescription for clozapine. Which of the following statements should the nurse include in the teaching?
Correct Answer: C
Rationale: The correct answer is C: Notify your provider if you develop a fever while taking this medication. This is important because clozapine can cause a serious condition called agranulocytosis, which can lead to fever and other signs of infection. Promptly informing the healthcare provider allows for monitoring and appropriate intervention.
Choice A is incorrect because ringing in the ears is not a commonly reported adverse effect of clozapine.
Choice B is also incorrect as diarrhea is not a common side effect of clozapine.
Choice D is incorrect because weight gain, not weight loss, is a more common side effect of clozapine.
Question 2 of 5
A nurse recently administered filgrastim intravenously to a client who has cancer and is receiving cytotoxic chemotherapy. For which of the following data, discovered after the medication was administered, should the nurse file an incident report?
Correct Answer: C
Rationale: The correct answer is C. The nurse should file an incident report because the client had chemotherapy 12 hours before the filgrastim was administered. This timing is crucial as filgrastim is typically given to boost neutrophil production after chemotherapy to prevent infections. Administering filgrastim too soon after chemotherapy may not be effective and could potentially harm the client. Option A is not a reason to file an incident report as flushing the IV line with dextrose 5% in water is a standard practice. Option B, the client's neutrophil count, is not a reason for an incident report as it is a baseline assessment. Option D, the temperature of the medication vial, is also not a reason for an incident report unless it specifically affected the medication's stability.
Question 3 of 5
A nurse is reviewing the medical record of an adult client who has a fever and a prescription for acetaminophen. Which of the following findings should the nurse identify as a contraindication for receiving this medication?
Correct Answer: A
Rationale: The correct answer is A: Alcohol use disorder. Acetaminophen is metabolized in the liver, and excessive alcohol consumption can lead to liver damage.
Therefore, in a client with alcohol use disorder, there is an increased risk of liver damage and toxicity when taking acetaminophen. Chronic kidney disease (
B) does not directly impact the metabolism of acetaminophen. Hepatitis B vaccine (
C) and diabetes mellitus (
D) do not contraindicate the use of acetaminophen.
Question 4 of 5
A nurse is administering naloxone to a client who has developed an adverse action to morphine. The nurse should identify which of the following findings as a therapeutic effect of naloxone?
Correct Answer: B
Rationale: The correct answer is B: Increased respiratory rate. Naloxone is an opioid antagonist that reverses the effects of opioid medications like morphine. Morphine can cause respiratory depression, so administering naloxone will reverse this effect, leading to an increase in the client's respiratory rate. This is a therapeutic effect as it helps restore normal breathing and prevent further complications.
Incorrect choices:
A: Increased pain relief - Naloxone does not directly provide pain relief but reverses the effects of opioids.
C: Decreased blood pressure - Naloxone may cause a transient increase in blood pressure due to its stimulatory effect on the body.
D: Decreased nausea - Naloxone does not directly affect nausea but focuses on reversing opioid effects.
Question 5 of 5
A nurse is assessing for allergies with a client who is scheduled to receive the influenza vaccine. Which of the following allergies should the nurse report to the provider as a possible contraindication to receiving the vaccine?
Correct Answer: D
Rationale: The correct answer is D: Eggs. The influenza vaccine is typically produced using eggs, so individuals with a known allergy to eggs should not receive the vaccine due to the risk of an allergic reaction. Reporting this allergy to the provider is crucial to prevent any adverse effects.
Choices A, B, and C are unrelated to the influenza vaccine and do not pose a contraindication. Reporting the egg allergy ensures the safety of the client during vaccination.